Looking for a portfolio that balances steady growth with sector-specific strength? The Steady Improvers portfolio is designed as a sector ETF alternative, focusing on the best growth stocks in healthcare and technology for Q1 2026 and beyond. With a Tradestie Score of 55.8762/100 and a Diversification Score of 66.9/100, this 10-stock portfolio targets consistent performers in high-potential industries, allocating 60% to healthcare stocks, 30% to the technology sector, and 10% to industrials. It’s crafted for investors seeking undervalued stocks with strong upside potential in the 2026 market outlook.
Stock selection prioritizes innovation and resilience, featuring leaders like Align Technology Inc (ALGN) at 11.7%, a pioneer in dental and orthodontic solutions, and Alkermes Plc (ALKS), also at 11.7%, with promising biopharma developments. Amgen Inc (AMGN) at 9.7% offers stability in healthcare, while agilon health Inc (AGL) at 8.7% taps into aging population trends. In technology, Automatic Data Processing Inc (ADP) at 9.7% and Amphenol Corporation (APH) at 11.7% stand out as tech stocks to buy, driven by automation and connectivity trends. CCC Intelligent Solutions Holdings Inc. (CCC) at 8.7% adds cutting-edge software exposure. Industrials like Armstrong World Industries Inc (AWI) at 9.7% round out the mix with cyclical growth potential. These picks are chosen for their current valuation and projected growth through 2026.
Ideal for the beginner investor or those building a retirement portfolio, Steady Improvers suits moderate risk-takers eyeing aggressive growth in healthcare and tech. However, investors should note sector-specific risks, including regulatory changes in healthcare stocks and volatility in the technology sector. Market fluctuations could impact returns, so staying informed on the 2026 market outlook is key to navigating potential challenges.